Home › Funds › Shepherd Street Advisors LLC › VRTX

Shepherd Street Advisors LLC position in VRTX

VERTEX PHARMACEUTICALS INC · Health Care

Shepherd Street Advisors LLC reported holding 3,199 shares of VRTX (VERTEX PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$1.6M, representing 1.40% of its reported portfolio and ranking #26 among its reported holdings. Shepherd Street Advisors LLC has disclosed VRTX holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)3.20K sh
Reported value held$1.63M
Portfolio Weight1.40%
First reportedQ4 2025
Last changeAdd
Updated2026-10-21

Last updated: 2026-10-21 · Source: SEC EDGAR Form 13F-HR

How Shepherd Street Advisors LLC's VRTX position evolved

Shepherd Street Advisors LLC first disclosed a stake in VRTX in Q4 2025 at 2,995 shares (US$1.4M). The position peaked in Q3 2026 at 3,199 shares, worth US$1.6M. Across 4 filings, Shepherd Street Advisors LLC increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 3,199 shares valued at US$1.6M — an increase of 31 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q4 2025 3.00K $1.36M New
Q1 2026 3.22K $1.44M Add
Q2 2026 3.17K $1.51M Reduce
Q3 2026 3.20K $1.63M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About VRTX and 13F data

VRTX (VERTEX PHARMACEUTICALS INC) is a Health Care company. 33 other funds we track also report a position in VRTX — the largest reported positions include Capital World Investors (US$12.97B), Capital World Investors (US$12.97B), Capital Research Global Investors (US$9.68B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VRTX

All VRTX fund holders →

FAQ

How long has Shepherd Street Advisors LLC held VRTX?

Shepherd Street Advisors LLC has disclosed VRTX holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is Shepherd Street Advisors LLC's current position in VRTX?

As of Q3 2026, Shepherd Street Advisors LLC holds 3.20K shares of VRTX (VERTEX PHARMACEUTICALS INC), valued at $1.63M, representing 1.40% of its reported portfolio and ranking #26.

Has Shepherd Street Advisors LLC been buying or selling VRTX?

In the latest 13F filing (Q3 2026), Shepherd Street Advisors LLC increased its position in VRTX. The position peaked in Q3 2026 at 3.20K shares.

Which other funds hold VRTX?

Other major institutional holders of VRTX include Capital World Investors, Capital World Investors, Capital Research Global Investors, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.